The startup develops radiopharmaceuticals that utilize novel radioactive molecules for targeted imaging and treatment of solid tumors. By enhancing the visualization and therapeutic targeting of aggressive cancers, the company aims to improve diagnostic accuracy and treatment efficacy for oncologists.

Capitainer develops microsampling devices that enable patients to collect precise volumes of whole blood, plasma, or fluids at home using capillary finger blood, eliminating the need for trained phlebotomists. This technology facilitates remote clinical diagnostics by providing accurate, quantitative samples that can be mailed for laboratory analysis, improving accessibility and efficiency in healthcare monitoring.

The startup develops rapid diagnostic kits for infectious diseases, focusing on point-of-care testing for tuberculosis and sexually transmitted infections using combinatorial and confirmatory methods. These kits enable early-stage diagnosis, allowing patients to receive timely and accurate results at the point of care.

The startup develops personalized cancer immunotherapy that identifies optimal neoantigens to target and activate T-lymphocytes for the precise elimination of cancer cells. This approach aims to enhance patient recovery by tailoring treatments to individual tumor profiles, improving efficacy in cancer management.

PeptiSystems manufactures fully automated synthesizers utilizing continuous flow technology for the production of peptide and oligonucleotide therapeutics, significantly reducing synthesis time from weeks to just 1-3 hours. Their systems provide real-time monitoring and consistent scalability, enabling efficient process development and large-scale manufacturing while improving yield and purity by up to 15%.

TIRmed Pharma is developing TIR-01, a topical cream that modulates immune responses to alleviate mild to moderate eczema symptoms by reducing itch and promoting tissue regeneration. This non-invasive treatment offers a sustained effect without complete immune suppression, addressing the need for effective alternatives to steroid-based therapies.